UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034161
Receipt number R000038944
Scientific Title Effects of electrolyzed water on attenuating fatigue induced by cognitive task
Date of disclosure of the study information 2018/10/22
Last modified on 2019/03/18 11:49:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of electrolyzed water on attenuating fatigue induced by cognitive task

Acronym

Effects of electrolyzed water on attenuating fatigue induced by cognitive task

Scientific Title

Effects of electrolyzed water on attenuating fatigue induced by cognitive task

Scientific Title:Acronym

Effects of electrolyzed water on attenuating fatigue induced by cognitive task

Region

Japan


Condition

Condition

Helathy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of electrolized water on attenuating fatigue induced by cognitive task

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Biomarkers related to fatigue and inflammation

Key secondary outcomes

Performance level of Cognitive task
Subjective fatigue level
Autonomic nervous system


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of test water for single time

Interventions/Control_2

Ingestion of placebo water for single time

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy persons aged from 20 to 64 years

Key exclusion criteria

1. Persons who are in treatment
2. Persons who have medical history of
circulatory system disease
3. Persons who have disorders of
autonomic nervous system
4. Persons who have medical history of
nervous system disease such as unconsciousness, coma, and convulsion, and so on
5. Persons who have sleep disorder
6. Persons who have food allergy
7. persons who are heavy user of alcohol
8. Persons whose BMI is less 17 or over 31
9. Persons who usually take hydrogen-
rich water
10. Persons who have medical history of
diabetes, hepathopathy, kidney disease, and heart disease
11. Persons who participate in another
clinical study in one month before giving informed consent of the present study or are now participating in another clinical
study
12. Persons who are or may be pregnant,
or nursing
13. Persons who smoke
14. Persons who engage in night shift work
15. Persons who are judged not suitable
to participate inthis trial by researchers

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuyoshi Watanabe

Organization

RIKEN Center for Biosystems Dynamics Research (BDR) /Osaka City University

Division name

Laboratory for Pathophysiological and Health Science /Center for Health Science Innovation

Zip code


Address

6-7-3 Minatojima minamimachi, Chuo-ku, Kobe

TEL

06-6845-0288

Email

yywata@riken.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazunobu Okazaki

Organization

Osaka City University

Division name

Center for Health Science Innovation

Zip code


Address

Knowledge Capital, Grand Front Osaka, 3-1, Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL

06-6845-0288

Homepage URL


Email

chsi-b@ado.osaka-cu.ac.jp


Sponsor or person

Institute

RIKEN Center for Biosystems Dynamics Research (BDR) /Osaka City University Center for Health Science Innovation

Institute

Department

Personal name



Funding Source

Organization

NIHON TRIM CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

Kobe 2 2017-06

Org. issuing International ID_1

RIKEN

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪市立大学 健康科学イノベーションセンター(大阪府)


Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 07 Month 20 Day

Date of IRB

2018 Year 07 Month 23 Day

Anticipated trial start date

2018 Year 09 Month 07 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 15 Day

Last modified on

2019 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038944


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name